Historical record - last NADAC effective date: 6/23/2021

Product Information

SEVELAMER CARBONATE 800 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.2953 per EA under NDC 69097089393. Its NADAC has been published 182 times since Jan 10, 2018.

FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SEVELAMER CARBONATE 800 MG TAB

SEVELAMER CARBONATE
$0.2953per EA

Strength

800 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097089393

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

6/23/2021

Active Ingredients

SEVELAMER CARBONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203860

FDA Approved

10/26/2017

TE Code

AB

On Market Since

10/26/2017

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for SEVELAMER CARBONATE 800 MG TAB has been published 182 times since Jan 10, 2018, and over the history we have for it it has declined 92.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2953 per EA
All-time high$3.6808 (Jan 10, 2018)
All-time low$0.2602 (Jan 20, 2021)
Median price$0.4386
Average price$0.6897
Largest weekly change-32.7% (Jan 17, 2018)
Weeks tracked182
Tracking sinceJan 10, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-92.0%

Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SEVELAMER CARBONATE 800 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER CARBONATE 800 MG TAB, manufactured by Cipla USA Inc., is $0.2953 per EA (NDC 69097089393), effective Jun 30, 2021.

How has the price of SEVELAMER CARBONATE 800 MG TAB changed over time?

Over the history we have for it, the NADAC for SEVELAMER CARBONATE 800 MG TAB has declined 92.0%. It has been tracked across 182 weekly CMS publications since Jan 10, 2018.

What are the highest and lowest recorded NADAC prices for SEVELAMER CARBONATE 800 MG TAB?

Since Jan 10, 2018, the NADAC for SEVELAMER CARBONATE 800 MG TAB has ranged from a low of $0.2602 (Jan 20, 2021) to a high of $3.6808 (Jan 10, 2018), with a median of $0.4386 per EA.

Are there cheaper alternatives to SEVELAMER CARBONATE 800 MG TAB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SEVELAMER CARBONATE 800 MG TAB, is $0.2186 per EA — about 26% below SEVELAMER CARBONATE 800 MG TAB.

Who manufactures SEVELAMER CARBONATE 800 MG TAB?

SEVELAMER CARBONATE 800 MG TAB (NDC 69097089393) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.